Repligen (RGEN) Total Current Liabilities (2011 - 2026)
Repligen (RGEN) posted quarterly Total Current Liabilities of $132.7 million for Q2 2026, up 7.84% year-over-year from $123.0 million in Q2 2025, and up 5.11% quarter-over-quarter from $126.2 million in Q1 2026.
Repligen (RGEN) Total Current Liabilities (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Total Current Liabilities for 16 consecutive years, with $132.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 7.84% year-over-year to $132.7 million; the TTM figure through Jun 2026 stood at $132.7 million (up 7.84% YoY), while the FY2025 annual figure was $135.8 million, up 7.13% from the prior year.
- Total Current Liabilities grew to $132.7 million in Q2 2026 per RGEN's latest filing, from $126.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $424.3 million in Q1 2022 and bottomed at $108.4 million in Q3 2024.
- Historically, Total Current Liabilities has averaged $244.7 million across 5 years, with a median of $169.9 million in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 35.43% — and 2024, when it sank 71.4%.
- Repligen's Total Current Liabilities stood at $404.2 million in 2022, then plunged by 59.19% to $164.9 million in 2023, then dropped by 23.13% to $126.8 million in 2024, then rose by 7.13% to $135.8 million in 2025, then retreated by 2.33% to $132.7 million in 2026.
- Business Quant data shows RGEN's Total Current Liabilities at $132.7 million in Q2 2026, $126.2 million in Q1 2026, and $135.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 132.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 132.66 Mn |
| Mar 31, 2026 | 126.21 Mn |
| Dec 31, 2025 | 135.83 Mn |
| Sep 30, 2025 | 131.14 Mn |
| Jun 30, 2025 | 123.01 Mn |
| Mar 31, 2025 | 152.00 Mn |
| Dec 31, 2024 | 126.79 Mn |
| Sep 30, 2024 | 108.37 Mn |
| Jun 30, 2024 | 174.81 Mn |
| Mar 31, 2024 | 181.55 Mn |
| Dec 31, 2023 | 164.94 Mn |
| Sep 30, 2023 | 378.94 Mn |
| Jun 30, 2023 | 388.35 Mn |
| Mar 31, 2023 | 416.56 Mn |
| Dec 31, 2022 | 404.20 Mn |
| Sep 30, 2022 | 410.70 Mn |
| Jun 30, 2022 | 423.52 Mn |
| Mar 31, 2022 | 424.33 Mn |
| Dec 31, 2021 | 375.26 Mn |
| Sep 30, 2021 | 349.44 Mn |